Can-Fite BioPharma Ltd. sell Lokrim
Start price
14.11.21
/
20%
€11.60
Target price
14.11.22
-
Performance (%)
-33.62%
End price
15.11.22
€7.70
Summary
This prediction ended on 15.11.22 with a price of €7.70. Lokrim correctly predicted massive losses of -33.62% for Can-Fite BioPharma Ltd.. Lokrim has 20% into this prediction This prediction was marked as speculative and is excluded from Lokrim's performance statistics.Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Can-Fite BioPharma Ltd. | - | - | - | - |
| iShares Core DAX® | -0,68 % | 4,05 % | 2,21 % | 52,79 % |
| iShares Nasdaq 100 | 0,99 % | 10,87 % | 38,04 % | 94,87 % |
| iShares Nikkei 225® | 3,28 % | 13,47 % | 59,00 % | 70,29 % |
| iShares S&P 500 | 0,62 % | 6,20 % | 26,15 % | 68,91 % |
According to Lokrim what are the pros and cons of Can-Fite BioPharma Ltd. for the foreseeable future?
Pros
Cons
Probably not worthwhile Investment
Comments by Lokrim for this prediction
In the thread Can-fite Biopharma Ltd. diskutieren
Sell Can-fite Biopharma Ltd.
In the thread Trading Can-fite Biopharma Ltd.
Die von Lokrim gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Lokrim for Can-Fite BioPharma Ltd.
Can-Fite BioPharma Ltd.
Start price
Target price
Perf. (%)
€21.80
22.02.21
22.02.21
-
22.02.22
22.02.22
-46.79%
14.11.21
14.11.21
Probably not worthwhile Investment
